These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23228313)

  • 1. Levosimendan preoperative.
    Rognoni A; Lupi A; Cavallino C; Veia A; Bacchini S; Rosso R; Secco GG; Bongo AS
    Curr Pharm Des; 2013; 19(22):3974-8. PubMed ID: 23228313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan: a new era for inodilator therapy for heart failure?
    Cleland JG; McGowan J
    Curr Opin Cardiol; 2002 May; 17(3):257-65. PubMed ID: 12015475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the risk of major elective non-cardiac surgery: is there a role for levosimendan in the preoperative optimization of cardiac function?
    Morelli A; Ertmer C; Pietropaoli P; Westphal M
    Curr Drug Targets; 2009 Sep; 10(9):863-71. PubMed ID: 19799540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan: a novel agent in heart failure.
    Koumallos N; Antoniades C; Tousoulis D; Shirodaria C; Stefanadis C
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):185-91. PubMed ID: 18221085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan use in several scenarios of acute heart failure.
    Tavares M; Andrade AC; Mebazaa A
    Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan: a parenteral calcium-sensitising drug with additional vasodilatory properties.
    Lehtonen LA
    Expert Opin Investig Drugs; 2001 May; 10(5):955-70. PubMed ID: 11322869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan in cardiac surgery.
    Siirilä-Waris K; Suojaranta-Ylinen R; Harjola VP
    J Cardiothorac Vasc Anesth; 2005 Jun; 19(3):345-9. PubMed ID: 16130062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of levosimendan in patients with ischemic heart disease following mechanical reperfusion.
    Kurt IH
    Surg Today; 2009; 39(5):381-6. PubMed ID: 19408074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
    Lehtonen L
    Curr Heart Fail Rep; 2004 Sep; 1(3):136-44. PubMed ID: 16036037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of levosimendan in the treatment of heart failure.
    Kasikcioglu HA; Cam N
    Vasc Health Risk Manag; 2006; 2(4):389-400. PubMed ID: 17323593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion.
    Toller W; Heringlake M; Guarracino F; Algotsson L; Alvarez J; Argyriadou H; Ben-Gal T; Černý V; Cholley B; Eremenko A; Guerrero-Orriach JL; Järvelä K; Karanovic N; Kivikko M; Lahtinen P; Lomivorotov V; Mehta RH; Mušič Š; Pollesello P; Rex S; Riha H; Rudiger A; Salmenperä M; Szudi L; Tritapepe L; Wyncoll D; Öwall A
    Int J Cardiol; 2015 Apr; 184():323-336. PubMed ID: 25734940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricuspid valve replacement and levosimendan.
    Cicekcioglu F; Parlar AI; Altinay L; Yay K; Katircioglu SF
    Gen Thorac Cardiovasc Surg; 2008 Nov; 56(11):559-62. PubMed ID: 19002757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan: from basic science to clinical trials.
    Rognoni A; Lupi A; Lazzero M; Bongo AS; Rognoni G
    Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):9-15. PubMed ID: 21208157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan improves renal outcome in cardiac surgery: a randomized trial.
    Baysal A; Yanartas M; Dogukan M; Gundogus N; Kocak T; Koksal C
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):586-94. PubMed ID: 24447501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan, a new inotropic and vasodilator agent.
    Toller WG; Stranz C
    Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. eComment. Preoperative levosimendan administration in cardiac surgery patients.
    Yavuz S; Eris C; Ata Y; Turk T
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):714-5. PubMed ID: 24065757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.